Related Experiment Video
Updated: Mar 12, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Co-localized genomic regulation of miRNA and mRNA via DNA methylation affects survival in multiple tumor types
James D Doecke1, Ying Wang2, Keith Baggerly2
1Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA; Commonwealth Scientific and Industrial Research Organization (CSIRO) Health and Biosecurity/Australian E-Health Research Centre, Royal Brisbane and Women's Hospital, Level 5, UQ Health Sciences Building, 901/16, Herston, Queensland 4029, Australia.
Abstract:
Aberrant gene expression in cancer is due in part to irregular patterns of DNA methylation and miRNA target gene down regulation. Using data from The Cancer Genome Atlas (TGCA), we investigated co-localized mRNA, miRNA and DNA methylation data across 15 cancer types, focusing on cases where evidence for direct regulation was strong. Restricting attention to regions where miRNA markers co-localize within a corresponding mRNA transcript, we checked expression data from 2839 samples for 354 mRNAs, 389 miRNAs and 13,809 DNA methylation probes for correlations greater than an absolute 0.6. We identified 32 genes, 34 miRNAs and 143 DNA methylation site probes comprising 180 "triplet combinations" that together provide evidence of co-localized genomic regulation in cancer. The five triplet combinations showing the highest prevalence across tissue types were found in four genes, HOXC5, PDE2A, SH3TC2 and TP63. Of the total 32 genes, eight among two tumor types (Kidney Renal Clear Cell Carcinoma (KIRC, 4) and Low Grade Glioma (LGG, 4)) were significantly associated with survival time (p < 0.002). Together, the data presented in this paper provide evidence toward our primary hypothesis, that both genes and miRNAs strongly correlated with methylation level are more likely to be associated with cancer outcomes.
Insights
Aberrant gene expression in cancer involves DNA methylation and microRNA (miRNA) regulation. This study identified genomic "triplet combinations" linking DNA methylation, miRNA, and mRNA, revealing patterns associated with cancer patient survival.
Area of Science:
- Genomics
- Cancer Biology
- Epigenetics
Background:
- Aberrant gene expression in cancer is linked to irregular DNA methylation and microRNA (miRNA) target gene downregulation.
- Understanding these regulatory mechanisms is crucial for cancer research.
Purpose of the Study:
- To investigate co-localized mRNA, miRNA, and DNA methylation data across 15 cancer types.
- To identify genomic regulatory patterns associated with cancer outcomes.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) data for 2839 samples.
- Analyzed correlations (>0.6) between mRNA, miRNA, and DNA methylation probes within co-localized genomic regions.
- Identified 180 "triplet combinations" indicating co-localized genomic regulation.
Main Results:
- Identified 32 genes, 34 miRNAs, and 143 DNA methylation sites forming 180 triplet combinations.
- HOXC5, PDE2A, SH3TC2, and TP63 showed high prevalence of these combinations.
- Eight genes were significantly associated with survival in Kidney Renal Clear Cell Carcinoma and Low Grade Glioma.
Conclusions:
- Data support the hypothesis that genes and miRNAs strongly correlated with DNA methylation levels are associated with cancer outcomes.
- Identified specific regulatory triplets and genes linked to cancer survival, offering potential biomarkers.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

